CLARK GEORGE C. (VP, Chief Accounting Officer) sold 50.8% of their position (4.20K shares) of BIOHAVEN PHARMACEUTICAL HOLDING CO LTD. on the open market
Open‑market sale worth $594.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/12/2022ACC: 0001562180-22-004014
Officer· VP, Chief Accounting Officer
Since Aug 2021
-4.20K
Net shares
Net seller
$594.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
2.25K acquired · 6.45K disposed
Non-Derivative Transactions2
Common Shares
Direct
Shares
+2.25K
Price / share
$53.76
Trade value
$120.96K
% of position
37.4%
5/10/2022
6.01K→8.27K
Common Shares
Direct
Shares
−4.20K
Price / share
$141.50
Trade value
$594.30K
% of position
50.8%
5/10/2022
8.27K→4.07K
Total
Net shares
−1.95K
Net value
-$473.34K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Direct | 5/10/2022 | M · Option Exercise | +2.25K | $53.76 | $120.96K | 37.4% | 6.01K | 8.27K |
| Common Shares Direct | 5/10/2022 | S · Sale | −4.20K | $141.50 | $594.30K | 50.8% | 8.27K | 4.07K |
| Total | −1.95K | -$473.34K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Shares
2.25K shares
Shares
−2.25K
Strike price
53.76
Held after
2.25K
Exercisable
—
5/10/2022
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Shares2.25K shares | 5/10/2022 | M · Option Exercise | −2.25K | 53.76 | — | 2.25K |